The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma

BACKGROUND: Medulloblastoma is a leading cause of childhood cancer-related deaths. Current aggressive treatments frequently lead to cognitive and neurological disabilities in survivors. Novel targeted therapies are required to improve outcome in high-risk medulloblastoma patients and quality of life...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajtler, Kristian W, Weingarten, Christina, Thor, Theresa, Künkele, Annette, Heukamp, Lukas C, Büttner, Reinhard, Suzuki, Takayoshi, Miyata, Naoki, Grotzer, Michael, Rieb, Anja, Sprüssel, Annika, Eggert, Angelika, Schramm, Alexander, Schulte, Johannes H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893444/
https://www.ncbi.nlm.nih.gov/pubmed/24252778
http://dx.doi.org/10.1186/2051-5960-1-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893444/
https://www.ncbi.nlm.nih.gov/pubmed/24252778
http://dx.doi.org/10.1186/2051-5960-1-19

Ejemplares similares